Cargando…
Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC
Low skeletal muscle mass is a well-known prognostic factor for patients treated for a non-small-cell lung cancer by surgery or chemotherapy. However, its impact in patients treated by exclusive radiochemotherapy has never been explored. Our study tries to evaluate the prognostic value of low skeleta...
Autores principales: | Mallet, R., Decazes, P., Modzelewski, R., Lequesne, J., Vera, P., Dubray, B., Thureau, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137692/ https://www.ncbi.nlm.nih.gov/pubmed/34017035 http://dx.doi.org/10.1038/s41598-021-90187-6 |
Ejemplares similares
-
Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer
por: Mallet, Romain, et al.
Publicado: (2020) -
Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy
por: Thureau, Sébastien, et al.
Publicado: (2021) -
Impact of the Bayesian penalized likelihood algorithm (Q.Clear®) in comparison with the OSEM reconstruction on low contrast PET hypoxic images
por: Texte, Edgar, et al.
Publicado: (2020) -
Prognostic value of post-induction chemotherapy (18)F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation
por: Ganem, Julien, et al.
Publicado: (2019) -
Delineation of lung cancer with FDG PET/CT during radiation therapy
por: Ganem, J., et al.
Publicado: (2018)